| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 42, 707-717, Copyright © 1976 by Endocrine Society
ARTICLES |
CS Anast, JL Winnacker, LR Forte and TW Burns
Parathyroid hormone release and end-organ responsiveness to parathyroid extract (PTE) were evaluated in a 25-year-old woman with magnesium deficiency associated with hypocalcemia and inappropriately low levels of serum immunoreactive parathyroid hormone (iPTH). End-organ responsiveness to PTE was demonstrated by increases in serum calcium and in urinary phosphorus, cyclic AMP, and hydroxyproline. When the serum calcium was increased from a baseline of 6.9 mg/100 ml to levels of 8.0 mg/100 ml and higher by calcium infusion, the serum iPTH decreased from the low normal range to below the limits of detectability. The intravenous administration of 3 mg/kg of body weight of magnesium led to an abrupt and striking increase in circulating iPTH with a 2-fold increase in one minute, a 6-fold increase in two minutes, and an 8-fold increase in five minutes. The very rapid increase in serum iPTH produced by magnesium infusion in this study suggests an effect of magnesium on hormone secretion rather than an effect on hormone synthesis. The evidence provided by this investigation indicates that the release of parathyroid hormone is impaired in magnesium deficiency and that the level of circulating calcium required for the suppression of parathyroid hormone secretion is lower than that in normal subjects.
This article has been cited by other articles:
![]() |
M. D. Kraft, I. F. Btaiche, and G. S. Sacks Review of the Refeeding Syndrome Nutr Clin Pract, December 1, 2005; 20(6): 625 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Kraft, I. F. Btaiche, G. S. Sacks, and K. A. Kudsk Treatment of electrolyte disorders in adult patients in the intensive care unit Am. J. Health Syst. Pharm., August 15, 2005; 62(16): 1663 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. Dai, G. Ritchie, D. Kerstan, H. S. Kang, D. E. C. Cole, and G. A. Quamme Magnesium Transport in the Renal Distal Convoluted Tubule Physiol Rev, January 1, 2001; 81(1): 51 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Brown and R. J. MacLeod Extracellular Calcium Sensing and Extracellular Calcium Signaling Physiol Rev, January 1, 2001; 81(1): 239 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Huycke, M. T. Naguib, M. M. Stroemmel, K. Blick, K. Monti, S. Martin-Munley, and C. Kaufman A Double-Blind Placebo-Controlled Crossover Trial of Intravenous Magnesium Sulfate for Foscarnet-Induced Ionized Hypocalcemia and Hypomagnesemia in Patients with AIDS and Cytomegalovirus Infection Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2143 - 2148. [Abstract] [Full Text] |
||||
![]() |
R. Mihai and J. R. Farndon Parathyroid disease and calcium metabolism Br. J. Anaesth., July 1, 2000; 85(1): 29 - 43. [Full Text] [PDF] |
||||
![]() |
H. Shalev, M. Phillip, A. Galil, R. Carmi, and D. Landau Clinical presentation and outcome in primary familial hypomagnesaemia Arch. Dis. Child., February 1, 1998; 78(2): 127 - 130. [Abstract] [Full Text] |
||||
![]() |
B. F. Cuneo, C. B. Langman, M. N. Ilbawi, V. Ramakrishnan, A. Cutilletta, and D. A. Driscoll Latent Hypoparathyroidism in Children With Conotruncal Cardiac Defects Circulation, May 1, 1996; 93(9): 1702 - 1708. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |